Seminars in Thrombosis and Hemostasis

Papers
(The TQCC of Seminars in Thrombosis and Hemostasis is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
COVID-19 and Venous Thromboembolism: A Meta-analysis of Literature Studies188
SARS-2 Coronavirus–Associated Hemostatic Lung Abnormality in COVID-19: Is It Pulmonary Thrombosis or Pulmonary Embolism?72
Increased VWF and Decreased ADAMTS-13 in COVID-19: Creating a Milieu for (Micro)Thrombosis71
Coronavirus Disease 2019 Coagulopathy: Disseminated Intravascular Coagulation and Thrombotic Microangiopathy—Either, Neither, or Both68
Venous Thromboembolism in Patients Discharged after COVID-19 Hospitalization64
Different Anticoagulant Regimens, Mortality, and Bleeding in Hospitalized Patients with COVID-19: A Systematic Review and an Updated Meta-Analysis51
Impaired Breakdown of Bradykinin and Its Metabolites as a Possible Cause for Pulmonary Edema in COVID-19 Infection42
COVID-19 and Antiphospholipid Antibodies: Time for a Reality Check?41
Hematology Laboratory Abnormalities in Patients with Coronavirus Disease 2019 (COVID-19)39
Bleeding and Bleeding Risk in COVID-1938
Coronavirus Disease 2019, Prothrombotic Factors, and Venous Thromboembolism36
Coronavirus Disease 2019: The Role of the Fibrinolytic System from Transmission to Organ Injury and Sequelae35
Protective Effects of Statins Administration in European and North American Patients Infected with COVID-19: A Meta-Analysis33
Thrombin Generation and Cirrhosis: State of the Art and Perspectives33
Thrombin: A Pivotal Player in Hemostasis and Beyond31
Is Lupus Anticoagulant a Significant Feature of COVID-19? A Critical Appraisal of the Literature29
Relative Hypercoagulopathy of the SARS-CoV-2 Beta and Delta Variants when Compared to the Less Severe Omicron Variants Is Related to TEG Parameters, the Extent of Fibrin Amyloid Microclots, and the Se28
Hormonal Contraceptives and the Risk of Venous Thrombosis26
Presenting Characteristics, Treatment Patterns, and Outcomes among Patients with Venous Thromboembolism during Hospitalization for COVID-1925
Circulating Heparan Sulfate Proteoglycans as Biomarkers in Health and Disease25
Mean Platelet Volume Predicts Severe COVID-19 Illness22
Pulmonary Megakaryocytes in Coronavirus Disease 2019 (COVID-19): Roles in Thrombi and Fibrosis22
The Role of Fibrin(ogen) in Wound Healing and Infection Control22
Netting Liver Disease: Neutrophil Extracellular Traps in the Initiation and Exacerbation of Liver Pathology21
Patients with Congenital Bleeding Disorders Appear to be Less Severely Affected by SARS-CoV-2: Is Inherited Hypocoagulability Overcoming Acquired Hypercoagulability of Coronavirus Disease 2019 (COVID-21
Thrombopoietin Receptor Agonists in Patients with Chronic Liver Disease21
Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19)—Part I21
Thromboelastometry Variables in Neonates with Perinatal Hypoxia20
Thromboelastography-Guided Management of Anticoagulated COVID-19 Patients to Prevent Hemorrhage20
Circulating Plasminogen Concentration at Admission in Patients with Coronavirus Disease 2019 (COVID-19)19
The Role of Red Blood Cells in Hemostasis19
Cerebral Venous Thrombosis Developing after COVID-19 Vaccination: VITT, VATT, TTS, and More19
Past, Present, and Future Perspectives of Plasminogen Activator Inhibitor 1 (PAI-1)19
Endothelial Heparan Sulfate Proteoglycans in Sepsis: The Role of the Glycocalyx18
Platelet Activation and Thrombosis in COVID-1918
Coronavirus (COVID-19), Coagulation, and Exercise: Interactions That May Influence Health Outcomes18
Circulating Levels of Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 Are Independent Predictors of Coronavirus Disease 2019 Severity: A Prospective, Observational Study18
Use of Glucocorticoids and Risk of Venous Thromboembolism: A Narrative Review18
Rotational Thromboelastometry in Neonates Admitted to a Neonatal Intensive Care Unit: A Large Cross-sectional Study18
Spontaneous Muscle Hematoma in Patients with COVID-19: A Systematic Literature Review with Description of an Additional Case Series18
Biology of the Heparanase–Heparan Sulfate Axis and Its Role in Disease Pathogenesis17
A Review of Coagulation Abnormalities of Autoimmune Acquired Factor V Deficiency with a Focus on Japan17
Iron Oxide Nanoparticles as Imaging and Therapeutic Agents for Atherosclerosis17
Thrombosis and Hemostasis Issues in Cancer Patients with COVID-1917
Oral Contraceptives and Venous Thromboembolism: Focus on Testing that May Enable Prediction and Assessment of the Risk17
Platelet Function in Viral Immunity and SARS-CoV-2 Infection17
Snake Venoms in Diagnostic Hemostasis and Thrombosis17
New Insights into the Pathogenesis, Risk Factors, and Treatment of Portal Vein Thrombosis in Patients with Cirrhosis16
Mutations Accounting for Congenital Fibrinogen Disorders: An Update16
Perspectives on Platelet Heterogeneity and Host Immune Response in Coronavirus Disease 2019 (COVID-19)16
Plasma Antithrombin Values Are Significantly Decreased in Coronavirus Disease 2019 (COVID-19) Patients with Severe Illness16
Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Pediatric Venous Thromboembolism Treatment and Thromboprophylaxis: A Systematic Review of the Literature16
Advances in the Management of Cancer-Associated Thrombosis16
Incidence of Bleeding and Thrombosis in Patients with Liver Disease15
New-Onset Atrial Fibrillation in Sepsis: A Narrative Review15
Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19): Part II15
Confronting COVID-19: Issues in Hemophilia and Congenital Bleeding Disorders15
Arterial Thrombotic Events in Hospitalized COVID-19 Patients: A Short Review and Meta-Analysis15
The Impact of SARS-CoV-2 Infection on Blood Coagulation and Fibrinolytic Pathways: A Review of Prothrombotic Changes Caused by COVID-1915
Profile of Patients with Isolated Distal Deep Vein Thrombosis versus Proximal Deep Vein Thrombosis or Pulmonary Embolism: RE-COVERY DVT/PE Study14
Testing for Lupus Anticoagulants14
The More Recent History of Hemophilia Treatment14
Atypical Spontaneous Hematomas in a Patient with Severe Coronavirus Disease 2019 (COVID-19)14
Fibrinolysis in Acute and Chronic Cardiovascular Disease14
Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19)—Part III14
Sulodexide versus Control and the Risk of Thrombotic and Hemorrhagic Events: Meta-Analysis of Randomized Trials13
Fibrinolytic Alterations in Sepsis: Biomarkers and Future Treatment Targets13
D-dimers—“Normal” Levels versus Elevated Levels Due to a Range of Conditions, Including “D-dimeritis,” Inflammation, Thromboembolism, Disseminated Intravascular Coagulation, and COVID-1913
Direct Oral Anticoagulants Plasma Levels Measurement: Clinical Usefulness from Trials and Real-World Data13
What We Know (and Do not Know) Regarding the Pathogenesis of Pulmonary Thrombosis in COVID-1913
Viscoelastic Tests as Point-of-Care Tests in the Assessment and Management of Bleeding and Thrombosis in Liver Disease13
Thrombin Generation in Patients with Coronavirus Disease 201913
Dosage of Anticoagulants in Obesity: Recommendations Based on a Systematic Review13
Disseminated Intravascular Coagulation: The Past, Present, and Future Considerations13
Immune-Mediated Coagulopathy in COVID-19 Infection13
Contemporary Clinical Use of Aspirin: Mechanisms of Action, Current Concepts, Unresolved Questions, and Future Perspectives13
Solid Phase Assays for Antiphospholipid Antibodies12
Evaluating Performance of Contemporary and Historical von Willebrand Factor (VWF) Assays in the Laboratory Identification of von Willebrand Disease (VWD): The Australasian Experience12
Emerging Roles of Heparan Sulfate Proteoglycans in Viral Pathogenesis12
Pharmacotherapy for Prevention and Management of Thrombosis in COVID-1911
Current Challenges in the Peripartum Management of Women with von Willebrand Disease11
The Pathophysiological Role of Platelet-Derived Extracellular Vesicles11
Arterial Thrombosis in Patients with Antiphospholipid Syndrome: A Review and Meta-Analysis11
Utilization of the Caprini Score for Risk Stratification of the Arthroplasty Patient in the Prevention of Postoperative Venous Thrombosis11
COVID-19 and Sex-/Gender-Specific Differences: Understanding the Discrimination11
Single, Dual, and Triple Antithrombotic Therapy in Cancer Patients with Coronary Artery Disease: Searching for Evidence and Personalized Approaches11
To Anticoagulate or Not to Anticoagulate in COVID-19: Lessons after 2 Years11
Gene Therapy for Inherited Bleeding Disorders11
Laboratory Diagnosis of von Willebrand Disease (VWD): Geographical Perspectives11
Systemic Antiangiogenic Therapies for Bleeding in Hereditary Hemorrhagic Telangiectasia: A Practical, Evidence-Based Guide for Clinicians11
Anti-Xa Monitoring of Low-Molecular-Weight Heparin during Pregnancy: A Systematic Review11
Enhanced Half-Life Recombinant Factor VIII Concentrates for Hemophilia A: Insights from Pivotal and Extension Studies11
Hemostasis and Liver Regeneration11
Fibrinolysis in Patients with Liver Disease11
Clinical Performance of Nonvitamin K Antagonist Oral Anticoagulants in Real-World Obese Patients with Atrial Fibrillation10
Involvement of Inflammation in Venous Thromboembolic Disease: An Update in the Age of COVID-1910
Why, Whom, and How to Screen for Chronic Thromboembolic Pulmonary Hypertension after Acute Pulmonary Embolism10
Hyperfibrinolysis in Patients with Solid Malignant Neoplasms: A Systematic Review10
Platelet Function Testing: Update and Future Directions10
The Benefits of Heparin Use in COVID-19: Pleiotropic Antiviral Activity beyond Anticoagulant and Anti-Inflammatory Properties10
Celebrating 50 Years of Seminars in Thrombosis and Hemostasis—Part I10
Fibrinolysis in Traumatic Brain Injury: Diagnosis, Management, and Clinical Considerations10
The Clotting Trigger Is an Important Determinant for the Coagulation Pathway In Vivo or In Vitro—Inference from Data Review10
Laboratory Testing for Heparin-Induced Thrombocytopenia and Vaccine-Induced Immune Thrombotic Thrombocytopenia Antibodies: A Narrative Review10
ROTEM Testing for Direct Oral Anticoagulants10
The Biological Significance of von Willebrand Factor O-Linked Glycosylation10
Increased Levels of Inflammatory and Endothelial Biomarkers in Blood of Long COVID Patients Point to Thrombotic Endothelialitis10
Does Chronic Treatment with Oral Anticoagulants Ameliorate the Clinical Course of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Coronavirus Disease 2019 (COVID-19)?10
Platelet Function and Turnover in Essential Thrombocythemia: A Systematic Review10
Impaired Fibrinolysis in the Antiphospholipid Syndrome9
Investigating a Signal of Acquired Hemophilia Associated with COVID-19 Vaccination: A Systematic Case Review9
Cancer-Associated Splanchnic Vein Thrombosis9
Venous Thromboembolism among Critically Ill Children: A Narrative Review9
COVID-19 Vaccine-Associated Immune Thrombosis and Thrombocytopenia (VITT): Diagnostic Discrepancies and Global Implications9
Tranexamic Acid and Its Potential Anti-Inflammatory Effect: A Systematic Review9
Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19)—Part IV9
Type 2A and 2M von Willebrand Disease: Differences in Phenotypic Parameters According to the Affected Domain by Disease-Causing Variants and Assessment of Pathophysiological Mechanisms9
Post COVID-19 Arterial Thromboembolism: A Clear and Present Danger9
Oxford-AstraZeneca ChAdOx1 COVID-19 Vaccine Does Not Alter Platelet Aggregation9
The Art and Science of Building a Computational Model to Understand Hemostasis9
Cancer-Related Venous Thromboembolism: From Pathogenesis to Risk Assessment9
2020 Eberhard F. Mammen Award Announcements: Part I—Most Popular Articles9
Mechanisms of Bone Remodeling Disorder in Hemophilia9
Type 2B von Willebrand Disease in Pregnancy: A Systematic Literature Review9
Celebrating 50 Years of Seminars in Thrombosis and Hemostasis—Part II9
Factor VIII and Factor IX Activity Measurements for Hemophilia Diagnosis and Related Treatments8
Altered Fibrinolysis in Hematological Malignances8
The Spectrum of Disease Severity in Cirrhosis and Its Implications for Hemostasis8
Post-Pulmonary Embolism Syndrome and Functional Outcomes after Acute Pulmonary Embolism8
Fibrinolysis in Venous Thromboembolism8
Altered Fibrinolysis during and after Surgery8
COVID-19-Associated Pulmonary Embolism: Review of the Pathophysiology, Epidemiology, Prevention, Diagnosis, and Treatment8
One Hundred Years of Congenital Fibrinogen Disorders8
Diagnostic Testing for von Willebrand Disease: Trends and Insights from North American Laboratories over the Last Decade8
Cerebral Venous Thrombosis8
0.071004867553711